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Human ﬁbroblasts produce ceramide from sialyllactosylceramide on the plasma membranes. Siali-
dase Neu3 is known to be plasma membrane associated, while only indirect data suggest the plasma
membrane association of b-galactosidase and b-glucosidase. To determine the presence of b-galacto-
sidase and b-glucosidase on plasma membrane, cells were submitted to cell surface biotinylation.
Biotinylated proteins were puriﬁed by afﬁnity column and analyzed for enzymatic activities on
artiﬁcial substrates. Both enzyme activities were found associated with the cell surface and were
up-regulated in Neu3 overexpressing cells. These enzymes were capable to act on both artiﬁcial
and natural substrates without any addition of activator proteins or detergents and displayed a
trans activity in living cells.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Plasma membrane glycoconjugates show changes during cell
development and neoplastic transformation and are involved in
the processes of cell–cell recognition and signal transduction
through the membrane [1,2]. The neo-synthesis of the glycoconju-
gate oligosaccharide chains occurs in the Golgi apparatus by the
action of glycosyltransferases working on nucleotide activated sug-
ars, while their catabolism occurs in lysosomes by exo-glycohydro-
lases. Moreover, sialyltransferase, b-hexosaminidase, b-glucosidase
and sialidase Neu3 activities are also associated with the plasma
membrane [3,4], suggesting their role in the remodeling of plasma
membrane glycolipids and glycoproteins, thus contributing to
modify the glycoconjugate membrane composition and the mem-
brane organization and functions. Since it has been shown that
the cell surface repairing can be due to the regulated fusion of lyso-
somes with the plasma membrane [5], lysosomal glycohydrolases
might reach the cell surface where they can contribute to remod-
eling plasma membrane glycoconjugates composition. In fact, bio-
chemical and immunological evidences showed that plasma
membrane and lysosomal b-hexosaminidase are the same enzyme
[3]. On the other hand, the plasma membrane associated sialidase
Neu3 and b-glucosidase GBA2 (uniprotkb:Q9HCG7) have beenchemical Societies. Published by E
himica, Biochimica e Biotec-
o, Via Fratelli Cervi 93, 20090
no).demonstrated to be different enzymes with respect the corre-
sponding lysosomal glycohydrolases [6,7].
As previously observed [8], ceramide is produced from GM3 in
the plasma membrane of human ﬁbroblasts and the process still
occurs after blocking endocytosis and lysosomal activity. This sug-
gests that sialidase, b-galactosidase and b-glucosidase sequential
activities are associated with the cell surface.
In this paper, we isolated plasmamembranes from human ﬁbro-
blasts and by biochemical approaches demonstrated that they
contain sialidase Neu3, a b-galactosidase active on LacCer, and a b-
glucosidase active on GlcCer and sensitive to Conduritol B Epoxide
(CBE) inhibition,whose activities coordinated each other.Moreover,
these enzymes are capable to display a trans activitywithout need of
detergents or of the exogenous addition of activator proteins.
2. Materials and methods
2.1. Cell cultures
Mock and Neu3 overexpressing human skin ﬁbroblasts (Neu3
cells) [8] were cultured and propagated in EMEM supplemented
with 10% FBS, 1% glutamine, 1% penicillin/streptomycin and
50 lg/ml neomycin.
2.2. RNA isolation and RT-PCR analysis
Total RNA from mock and Neu3 cells was isolated and treated
with RNase-free DNase (Invitrogen). cDNA was synthesized usinglsevier B.V. All rights reserved.
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ampliﬁcation of GBA2 we used a forward primer 50-CTACGCA
GAAAGGAGTAG-30 and reverse primer 50-CTTGTATACCGCCTGT
AG-30 (size of the ampliﬁcated product: 154 bp), for GBA we used
a forward primer 50-TTGCTCTGCGAAACATCATC-30 and reverse pri-
mer 50-CCCAGAGGGACACAGAATGT-30 (size of the ampliﬁcated
product: 126 bp) and for GALC we used a forward primer 50-
TCCAGTTGCACAACTTCAGC-30 and reverse primer 50-TTGT GCTC
AGCATAGGCATC-30 (size of the ampliﬁcated product: 136 bp).
The cDNA of the housekeeping genes b-actin and glyceraldehyde-
3-phosphate dehydrogenase were used as control.
2.3. Biotinylation of cell surface proteins
Conﬂuent cells were incubated for 1hr in medium without ser-
um and then washed twice with ice-cold PBS (pH 8.0). Biotinyla-
tion was performed with 0.5 mg/ml of Sulfo-NHS-LC-Biotin
(Pierce) in Dulbecco’s PBS for 30 min at 4 C under gentle stirring
and then blocked using 100 mM Tris/HCl (pH 7.4). Cells were har-
vested in PBS, pelleted, re-suspended in a water solution contain-
ing 0.5% Triton X-100 with a cocktail of protease inhibitors, and
lysed on ice using a point sonicator (four times, 45 s). Post-nuclear
surnatant (PNS) was prepared by centrifuging cell homogenate for
5 min at 1300g.
2.4. Afﬁnity puriﬁcation
A glass column was carefully packed with 250 ll of Monomeric
Avidin UltraLink Resin (Pierce) and washed with ﬁve resin-bed vol-
umes of PBS. The column was then washed with three volumes of
2 mM D-Biotin in PBS. The reversible bound biotin was removed
with ﬁve volumes of 0.1 M glycine, pH 2.8. Five resin-bed volumes
of PBS were used to re-equilibrate column for sample binding.
One hundred micrograms of total proteins from biotinylated
mock and Neu3 cells was applied to the columns and the column
ﬂow was stopped for 30 min. To elute fractions containing not-bio-
tinylated proteins (BB fractions), column was washed with 10 vol-
umes of Binding Buffer (0.1% Triton X-100 in PBS), then
biotinylated proteins (EB fractions) were recovered with ﬁve re-
sin-bed volumes of Elution Buffer (2 mM D-Biotin in PBS).
2.5. Dot blot assay
Two microliters of each fraction was spotted on PVDF mem-
brane. After drying, PVDF was blocked with 5% milk in 0.05%
Tween 20 in Tris buffered saline for 1 h at room temperature and
incubated with HRP-streptavidin for 30 min. After three washes
with 0.1% Tween 20 in Tris buffered saline, the presence of biotin-
ylated proteins was assessed by chemiluminescence.
2.6. Western blot analysis
Equal volumes of each fractions collected from the afﬁnity col-
umn were loaded on SDS–PAGE. Proteins were then blotted on a
PVDF membrane and LAMP-2 and b-tubulin were recognized by
immunoblotting using a goat polyclonal antibody from Santa Cruz
and a mouse monoclonal antibody from Sigma, respectively. The
detection was assessed by chemiluminescence using the appropri-
ate secondary antibodies conjugated with the horse-radish
peroxidase.
2.7. Glycohydrolases assays
Glycohydrolases activities associated to PNS, to fractions ob-
tained by the afﬁnity column and to fresh homogenates prepared
in water, were determined [9] on the methylumbelliferyl-glycosideartiﬁcial substrates: 4-MUB-b-D-galactopyranoside (MUB-Gal), 4-
MUB-b-D-glucopyranoside (MUB-Glc) and 4-MUB-N-acetyl-a-D-
neuraminic acid (MUB-Neu5Ac) (Sigma). The substrates were pre-
pared at a ﬁnal concentration of 0.3 mM in 6.2 mM sodium acetate
buffer (pH 4.5), 0.1 mM albumin. For the b-galactosidase activity
assay, 0.2% of Triton X-100 was also necessary in the reaction
buffer.
The reaction mixtures were incubated at 37 C under stirring for
different time and then stopped by the addition of 1 ml of 0.25 M
glycine, pH 10.7. The ﬂuorescence was detected by Jasco 820-FP
ﬂuorometer.
Plasmamembrane associated b-galactosidase and b-glucosidase
activities on artiﬁcial substrates in living cells, were determined
solubilizing MUB-Gal and MUB-Glc in EMEM without serum and
phenol red (pH 7.4) at the ﬁnal concentration of 250 lM and
4.5 mM, respectively, and then added to a monolayer of cells. At
different times aliquots of the medium were ﬂuorometrically ana-
lyzed adding 10 volumes of 0.25 M glycine (pH 10.7). Fluorescence
associated to the cells was detected both by ﬂuorescent micros-
copy and by ﬂuorimetric analysis of the cells lysed in 0.25 M gly-
cine (pH 10.7).
Plasmamembrane associated b-galactosidase and b-glucosidase
activities on natural substrates in living cells were determined as
follow: 300 pmoles of [3-3H(sphingosine)]lactosylceramide [10]
were solubilized in ethanol and loaded on 0.3 cm2 plastic micro-
wells, under a gentle stream of nitrogen. After ﬁve washing with
EMEM containing 10% FCS, cells (3000 cells) were added and cul-
tured in normal cell culture medium (pH 7.4) for up 48 h. Cells
were then recovered by trypsinization followed by two washes
with PBS. Radioactive lipids attached to the plate were recovered
by repeated ethanol washes. Radioactive lipids were analyzed by
two-dimensional HPTLC using 110:40:6 CHCl3/CH3OH/H2O for
the ﬁrst run and 50:42:11 CHCl3/CH3OH/0.2% aqueous CaCl2 for
the second run [11]. Digital autoradiography of the HPTLC plates
was performed with a Beta-Imager 2000 instrument (Biospace)
and the radioactivity associated with individual lipids was deter-
mined with the speciﬁc b-Vision software. Control experiments
on the ceramide shed from ﬁbroblasts were performed by feeding
cells with radioactive lactosylceramide and then checking the lip-
ids remained attached to the plastic plate.
2.8. Inactivation of CBE-sensitive b-glucosidase
To induce the inactivation of b-glucosidase, living cells or cell
homogenates were incubated for 30 min at room temperature with
1 mM CBE dissolved in EMEM without FCS and phenol red or in
6.2 mM sodium acetate buffer (pH 4.5), 0.1 mM albumin, respec-
tively [12].3. Results and discussion
In human ﬁbroblasts, the overexpression of plasma membrane
associated sialidase Neu3 induced an increase of b-galactosidase
and b-glucosidase expression and activity (Figs. 1 and 3). These
cells had higher levels of ceramide with respect to mock cells, that
caused cell apoptosis. Our results determined that ceramide was
produced on the plasma membrane [8]. As known, Neu3 is a plas-
ma membrane associated enzyme, whereas b-galactosidase and b-
glucosidase activities could be ascribed to lysosomal enzymes
translocated to the plasma membrane during its repairing [5] or
to enzyme isoforms speciﬁcally associated with the plasma
membrane.
To study plasma membrane associated enzymes, extraction
procedures involving high salt concentrations or detergents, or
conventional cell subfractionation, can be used. However, we were
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Fig. 1. Agarose gel electrophoresis of the semi-quantitative RT-PCR of human GBA2,
GBA, GALC and of the human housekeeping genes b-actin and G3PDH in Neu3 (1)
and in mock cells (2).
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glucosidase activities to the plasma membranes as well to quantify
these activities. To do this, after preliminary experiments that gave
poor quantitative results, we developed a procedure by cell surface
protein biotinylation and separation on avidin afﬁnity columns,
displaying a yield of recovery over 98%. The isolation of plasma
membrane proteins exposed to the extracellular environment
was performed from mock and Neu3 cells. Fractions eluted from
the column were assayed for the biotinylated proteins by dot blot
and, to exclude that EB fractions were contaminated by proteins
coming from the inner of the cells (e.g. lysosomal enzymes), we
performed a Western blot to check for the distribution within BB
and EB fractions of speciﬁc marker proteins: the lysosome-associ-
ated membrane protein LAMP-2 and the cytoskeleton protein b-
tubulin. As shown in Fig. 2, biotinylated proteins were found in
the EB fractions whereas LAMP-2 and b-tubulin were detected only
in BB fractions that contain not-biotinylated proteins.
Cell homogenates and EB fractions were assayed for the enzy-
matic activities on the artiﬁcial substrates MUB-Gal, MUB-Glc
and MUB-Neu5Ac. As shown in Fig. 3, in Neu3 cells the b-galacto-
sidase and b-glucosidase activities were much higher than in mock
cells, particularly that of b-glucosidase which increased ninefold.
On the contrary, the total sialidase activity did not change between
the two cell lines.
Both mock and Neu3 cells displayed b-galactosidase, b-glucosi-
dase and sialidase activities associated with the plasma mem-
branes. The b-galactosidase and the b-glucosidase enzymatic
units associated with the surface of mock and Neu3 cells was,
respectively, 20% and 10% of the total, whereas enzymatic units
of plasma membrane sialidase was 3.35% in mock cells and 6.3%
in Neu3 cells. Fig. 3 shows the total cell enzyme activities and that
associated to the plasma membranes; the difference between theLAMP-2
2 9 10 EB  
BB
-tubulin
1
Biotin
Fig. 2. Distribution of biotinylated proteins, LAMP-2 and b-tubulin within BB and
EB fractions collected from the afﬁnity column on Neu3 cells was determined by dot
blot and Western blot.total cell associated- and the plasma membrane associated activity
corresponds mainly to lysosomal activity, of course it cannot be ex-
cluded that a minor portion could be present in cytoplasm or other
subcellular fractions. In the case of sialidases, as example, the total
cell activity is due to the sum of the lysosomal Neu1, the cytosolic
Neu2, the mitochondrial Neu4 and the plasma membrane associ-
ated Neu3 (5).
These results together with the increased expression of GALC
and GBA in Neu3 cells (see Fig. 1) suggest that the expression of
different enzymes of glycolipid metabolism might be concomi-
tantly regulated.
Among the different b-glucosidases described, GBA2, which is
codiﬁed by a different gene respect to the lysosomal b-glucosidase
(GBA1), was found associated with, or in proximity of the cell sur-
face [4]. Moreover, GBA1 and GBA2 are clearly distinct in their
speciﬁcity toward inhibitors. In particular GBA1 resulted irrevers-
ibly inhibited by CBE, whereas the GBA2 activity was completely
lost in the presence of several detergents. Thus, under our experi-
mental conditions we could not measure the activity of the GBA2
enzyme due to the presence of Triton X-100. No b-glucosidase
activity was found when we performed the assay in the presence
of both Triton X-100 and CBE. The b-glucosidase activity associated
with the biotinylated protein fraction was sensitive to CBE but not
to Triton X-100, in this sight resembling the behavior of GBA1.
These results suggest that, in addition to sialidase Neu3 and b-hex-
osaminidase, other glycohydrolases are associated with the exter-
nal side of the plasma membrane.
It is well known that most of the lysosomal glycohydrolases re-
quire assistance of activator proteins to exert their enzymatic
activity in vivo. In in vitro assays, using natural substrates, these
proteins can be substituted by appropriate detergents. An impor-
tant point is to demonstrate that the plasma membrane associated
activities were conserved in living cells. For Neu3 sialidase we have
already demonstrated its activity on glycoconjugates located at the
cell surface of neighboring cells [13]. To look for b-galactosidase
and b-glucosidase activities in living cells, we used both artiﬁcial
and natural substrates as described in Section 2.
The artiﬁcial substratesMUB-Gal orMUB-Glcwere administered
to cell monolayers and, after 1 h incubation, ﬂuorescencewas found
associated with the medium of mock and Neu3 cells (Fig. 4). Also in
this case, higher activities were detected in Neu3 cells. As controls
we veriﬁed that under our experimental conditions the artiﬁcial
substrates were not subjected to not-enzymatic hydrolysis, were
not subjected to hydrolysis by the enzymes released into the med-
iumand thatMUBderivatives did not enter into the cellswhere they
could be hydrolyzed by the lysosomal enzymes.
To follow the GBA2 activity, we performed the activity assay in
the presence of CBE and we found that the ﬂuorescence associated
with the cell medium, due to the enzymatic hydrolysis of the MUB-
Glc, was almost the same in both cell lines, suggesting that the in-
crease of the plasma membrane b-glucosidase activity in Neu3
cells was due to the presence of a CBE-sensitive enzyme, in accord-
ing to the results obtained from the puriﬁed cell surface proteins.
When we measured the activity of GBA2 on the cell lysates pre-
pared in water in presence of CBE, the b-galactosidase activity in
Neu3 cells resulted in a twofold increase respect to mock cells.
These data conﬁrm the presence of GBA2, but suggest that its
up-regulation in Neu3 cells was not associated to the external side
of the plasma membrane.
Then we analyzed the b-galactosidase and b-glucosidase mem-
brane associated activity in living cells on natural lactosylcera-
mide. Cells were cultured up to 48 h in microwells previously
loaded with [3-3H(sphingosine)]lactosylceramide. After this, cells
were carefully removed by trypsinization and the microwells were
extensively washed with ethanol to recover the radioactive lipids
inserted into the plastic surface. The ceramide production was
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Fig. 3. b-Galactosidase, b-glucosidase and sialidase activity on artiﬁcial substrates MUB-Gal, MUB-Glc and MUB-Neu5Ac evaluated in cell homogenate (dark grey bars) and in
puriﬁed cell surface proteins (light grey bars). Data are expressed as enzymatic units (pmoles/min) and speciﬁc enzyme activity (pmoles/min mg cell proteins). Data are the
mean ± S.D. of three different experiments. Statistical signiﬁcance of differences was determined by Student’s t-test. *P < 0.001 versus control.
2472 M. Aureli et al. / FEBS Letters 583 (2009) 2469–2473determined by TLC analysis. Fig. 5 shows that lactosylceramide
was progressively converted to ceramide in both cell types and
that Neu3 cells produced more ceramide than mock cells. To ex-
clude enzymatic activities of serum proteins on [3-3H(sphingo-
sine)]lactosylceramide, a well loaded with the substrate was
incubated with the cell culture medium. In addition to this, we
fed cells with tritiated lactosylceramide and we did not ﬁnd any
catabolic tritiated ceramide, produced in lysosomes, shed in the
medium.
Our experiments indicated that mock and Neu3 cells are able to
hydrolyze the natural substrate LacCer attached to a plastic surface
at pH 7.0 and without the addition of detergents and activator pro-
teins. This is in contrast with the reported properties of these
hydrolytic enzymes, whose activities, at least in lysosomes, are
known to require an acidic pH and a peculiar membrane composi-tion (e.g. a high enrichment in bis(monoacylglycero)phosphate)
capable to favor the formation of small and highly curved intra
lysosomal vesicles in which the glycolipid oligosaccharides pro-
trude into the lysosomal lumen, resulting accessible to the activa-
tor proteins for proper substrate presentation to the enzymes.
LacCer is highly dispersed into the plastic surface of microwells
used for the enzymatic assay. In this way its presentation to the
glycohydrolases is probably different from that occurring in a lyso-
somal membrane but suitable for a substrate-enzyme interaction
yielding hydrolysis without the involvement of activator proteins.
In conclusion, our results show that the enzymes b-galactosi-
dase, lysosomal b-glucosidase GBA1 (or a b-glucosidase isoform
with substrate speciﬁcity and sensitivity to inhibitors similar to
GBA1), and non-lysosomal b-glucosidase GBA2 are in part associ-
ated with the outer layer of plasma membranes and here they
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port displaying a trans activity.
References
[1] Hakomori, S.-I. (1996) Tumor malignancy deﬁned by aberrant glycosylation
and sphingo(glyco)lipid metabolism. Cancer Res. 56, 5309–5318.
[2] Hakomori, S. (2002) Glycosylation deﬁning cancer malignancy: new wine in
an old bottle. Proc. Natl. Acad. Sci. USA 99, 10231–10233.[3] Mencarelli, S., Cavalieri, C., Magini, A., Tancini, B., Basso, L., Lemansky, P.,
Hasilik, A., Li, Y.T., Chigorno, V., Orlacchio, A., Emiliani, C. and Sonnino, S.
(2005) Identiﬁcation of plasma membrane associated mature beta-
hexosaminidase A, active towards GM2 ganglioside, in human ﬁbroblasts.
FEBS Lett. 579, 5501–5506.
[4] van Weely, S., Brandsma, M., Strijland, A., Tager, J.M. and Aerts, J.M. (1993)
Demonstration of the existence of a second, non-lysosomal glucocerebrosidase
that is not deﬁcient in Gaucher disease. Biochim. Biophys. Acta 1181, 55–62.
[5] Reddy, A., Caler, E.V. and Andrews, N.W. (2001) Plasma membrane repair is
mediated by Ca(2+)-regulated exocytosis of lysosomes. Cell 106, 157–169.
[6] Monti, E., Bassi, M.T., Papini, N., Riboni, M., Manzoni, M., Venerando, B., Croci,
G., Preti, A., Ballabio, A., Tettamanti, G. and Borsani, G. (2000) Identiﬁcation
and expression of NEU3, a novel human sialidase associated to the plasma
membrane. Biochem. J. 349, 343–351.
[7] Matern, H., Boermans, H., Lottspeich, F. and Matern, S. (2001) Molecular
cloning and expression of human bile acid beta-glucosidase. J. Biol. Chem. 276,
37929–37933.
[8] Valaperta, R., Chigorno, V., Basso, L., Prinetti, A., Bresciani, R., Preti, A., Miyagi,
T. and Sonnino, S. (2006) Plasma membrane production of ceramide from
ganglioside GM3 in human ﬁbroblasts. Faseb J. 20, 1227–1229.
[9] Tettamanti, G., Lombardo, A., Marchesini, S., Giuliani, A., Berra, B., Di Donato, S.,
Rimoldi, M. and Bertagnolio, B. (1977) Lipid storage diseases: biochemical
diagnosis. Biochem. Exp. Biol. 13, 45–60.
[10] Sonnino, S., Ghidoni, R., Galli, G. and Tettamanti, G. (1978) On the structure of
a new, fucose containing ganglioside from pig cerebellum. J. Neurochem. 31,
947–956.
[11] Scandroglio, F., Loberto, N., Valsecchi, M., Chigorno, V., Prinetti, A. and Sonnino,
S. (2008) Thin layer chromatography of gangliosides, Glycoconj. J.
doi:10.1007/s10719-008-9145-5.
[12] Legler, G. (1977) Glucosidases. Methods Enzymol. 46, 368–381.
[13] Papini, N., Anastasia, L., Tringali, C., Croci, G., Bresciani, R., Yamaguchi, K.,
Miyagi, T., Preti, A., Prinetti, A., Prioni, S., Sonnino, S., Tettamanti, G.,
Venerando, B. and Monti, E. (2004) The plasma membrane-associated
sialidase MmNEU3 modiﬁes the ganglioside pattern of adjacent cells
supporting its involvement in cell-to-cell interactions. J. Biol. Chem. 279,
16989–16995.
